Cryoport Inc (CYRX) 1.66 $CYRX Cryoport Reminds All

New Post Public Reply Private Reply Replies (0) Message Board

Jun 5, 2016 at 4:15 AM

Cryoport Inc (CYRX) 1.66 $CYRX

Cryoport Reminds All Interested Parties That Today is the Final Day to Become a Rights Offering Record Date Holder
PR Newswire - Wed May 25, 8:15AM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (the "Company"

, the world's leading cryogenic logistics company,would like to remind the investment community that an investor must own CYRX, CYRXW or any other Cryoport warrants by 4:00 PM ET on Wednesday, May 25, 2016 in order to be considered a record date holder for purposes of the Rights Offering.
CYRX: 1.66 (-0.14)

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease
PR Newswire - Mon May 23, 7:00AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company for the life sciences industry, today announced that it will provide global logistics support to International Stem Cell Corporation's (OTCQB: ISCO) ("ISCO"

for its Phase I clinical trial in Australia for the treatment of moderate to severe Parkinson's disease. ISCO commenced patient enrollment for the study earlier this month.
CYRX: 1.66 (-0.14)

Cryoport Announces Share Pricing Period and Record Date for Shareholder and Warrant Holder Rights Offering
PR Newswire - Mon May 16, 7:49AM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"

, the world's leading cryogenic logistics company, announced today the pricing period and record date for its rights offering.
CYRX: 1.66 (-0.14)

Cryoport Agreement with Cryo Store BV Expands European Presence for its Best-in-Class Cryogenic Logistics Solutions
PR Newswire - Fri May 06, 8:15AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced that Cryo Store BV ("Cryo Store"

, a European biostorage company, will utilize Cryoport's cryogenic logistics solutions to better serve the logistics needs of life sciences customers. Cryo Store provides storage and distribution services for temperature-controlled goods to biotechnology and pharmaceutical companies in Europe.
CYRX: 1.66 (-0.14)

Cryoport Files S-1 Registration Statement for Rights Offering
PR Newswire - Fri Apr 29, 12:43PM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"

, the world's leading cryogenic logistics company, announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC"

for a rights offering to its shareholders and warrant holders of record.
CYRX: 1.66 (-0.14)

Cryoport Signs Strategic Partnership Deal With Worthington Industries
PR Newswire - Wed Apr 13, 7:00AM CDT
Cryoport, Inc. (NASDAQ: CYRX), the world's leading cryogenic logistics company, announced today that it has entered into a strategic partnership with Worthington Industries (NYSE: WOR), maker of cryogenic storage vessels and equipment. Through this partnership, Worthington's CryoScience by Taylor Wharton business will design and manufacture biostorage and logistics equipment for use in Cryoport's life sciences cryogenic logistics solutions.
CYRX: 1.66 (-0.14), WOR: 39.17 (+0.98)

Cryoport Chosen to Provide Cold Chain Logistics Support to ProteoGenex
PR Newswire - Mon Apr 04, 8:19AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced it is providing cryogenic logistics solutions that support ProteoGenex, Inc.'s ("ProteoGenex"

shipping of biological specimens, including PBMCs, BMMCs, frozen tissue, OCT-embedded tissue, blood serum, blood plasma, whole blood, RNA/DNA, and other bio-fluids.
CYRX: 1.66 (-0.14)

UPS Adds Cryogenic Shipping to Its Temperature-Sensitive Portfolio In Europe
PR Newswire - Tue Mar 15, 7:00AM CDT
UPS (NYSE: UPS) announced the launch of UPS Temperature True® Cryo in Europe, providing healthcare customers access to end-to-end product protection and capability to ship parcels in a cryogenic environment. The service includes real-time tracking and intervention, which, when combined with UPS's risk mitigation solutions and global network of control towers, will provide complete visibility for shipments at every stage of the supply chain journey.
CYRX: 1.66 (-0.14), UPS: 103.12 (+0.07)

Cryoport Supports ImmunoCellular Therapeutics' 120-Site Phase III Clinical Trial With Cold Chain Logistics
PR Newswire - Thu Mar 03, 7:00AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced that it will be supporting the cryogenic logistics requirements of ImmunoCellular Therapeutics' (NYSE MKT: IMUC) ("ImmunoCellular"

registrational Phase III glioblastoma clinical trial across 120 sites in North America and Europe. This clinical trial is designed to evaluate the safety and efficacy of ImmunoCellular's lead product candidate ICT-107, a patient-derived dendritic cell-based immunotherapy.
CYRX: 1.66 (-0.14), IMUC: 0.25 (+0.01)

Cryoport to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
PR Newswire - Thu Feb 04, 7:30AM CST
Cryoport, Inc. (NASDAQ: CYRX), the world's leading cryogenic logistics company, today announced that Jerrell Shelton, Chief Executive Officer of Cryoport, Inc, will present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference to be held at the Convene, 730 Third Avenue in New York City on Wednesday, February 10, 2016 at 10:15am ET.
CYRX: 1.66 (-0.14)

Cryoport to Report Third Quarter Fiscal 2016 Financial Results on February 8th
PR Newswire - Tue Feb 02, 7:00AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, today announced that the Company will release financial results for the third quarter fiscal year 2016 ended December 31, 2015 on February 8, 2016 before the market opens.
CYRX: 1.66 (-0.14)

Cryoport Introduces Its Advanced Cryogenic Logistics Solutions for IVF to the Cambodia and Czech Republic Markets
PR Newswire - Tue Jan 26, 7:30AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the leading global cryogenic logistics company for the life sciences industry, today announced the geographic expansion of its Reproductive Medicine (IVF) shipping and logistics solutions to include Cambodia and the Czech Republic.
CYRX: 1.66 (-0.14)

Cryoport Is Selected By Morphotek to Manage Cold Chain Logistics
BusinessWire - Wed Jan 13, 12:00PM CST
Cryoport, Inc. (NASDAQ:CYRX), ("Company"

, the world's leading cryogenic logistics company, and Morphotek(R) announced that Cryoport is providing end-to-end cold chain logistics support for shipments of Morphotek's research and development materials.
CYRX: 1.66 (-0.14)

Cryoport Announces Opening of New US Headquarters
PR Newswire - Tue Dec 08, 7:30AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced the opening of its new US headquarters in Irvine, CA. The purpose-built facility supports the Company's long-term expansion plans for its logistics operations and client-demanded scalability.
CYRX: 1.66 (-0.14)

Cryoport Revenues Climb 74% for the Second Quarter of Fiscal Year 2016
PR Newswire - Mon Nov 16, 7:00AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"

today announced financial results for the three and six month periods ended September 30, 2015.
CYRX: 1.66 (-0.14)

Cryoport Presenting at CAR-T Summit
BusinessWire - Wed Nov 11, 7:00AM CST
Cryoport, Inc. (OTCBB: CYRX), the leading provider of advanced cryogenic logistics solution, is pleased to announce that Mark Sawicki, Ph.D., chief commercial officer, will speak alongside Robin Hooker, healthcare marketing director for UPS, at the CAR-T Summit in Boston at 3:30 p.m. Nov. 13, 2015.
CYRX: 1.66 (-0.14)

Cryoport to Report Second Quarter Fiscal 2016 Financial Results
PR Newswire - Tue Nov 03, 4:19PM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, today announced that the Company will release financial results for the second quarter fiscal year 2016 ended September 30, 2015 on Monday, November 16th before the market opens.
CYRX: 1.66 (-0.14)

Cryoport Appoints Robert Hariri, MD, PhD to its Board of Directors
PR Newswire - Thu Oct 01, 7:00AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

today announced the appointment of Robert Hariri, MD, PhD to its Board of Directors.
CYRX: 1.66 (-0.14), MYOS: 1.53 (+0.01), CELG: 107.59 (-0.65), CELGZ: 1.31 (+0.01)

Cryoport Acquires Full IP Rights to Cryoportal(TM)
PR Newswire - Thu Sep 24, 8:56AM CDT
Cryoport, Inc. (NASDAQ:CYRX) ("Company"

today announced the purchase of certain intellectual property and intellectual property rights to the Cryoportal(TM) operating platform from KLATU Networks, LLC ("Klatu"

.
FDX: 163.82 (-0.98), CYRX: 1.66 (-0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Ares Commercial Real Estate Gears Up for Q3 Earnings

Earnings Season Descends on Ares Commercial Real Estate The hush before the storm is here, comrades. Ares Commercial Real Estate Corporation (NYSE: ACRE) has set the ticker tape rolling as they prepare to unveil the fiscal secrets of their third quarter on November 6, 2026. If you’ve got skin in the game or just an ear for market music, mark your calendars because the...

HumanView Relaunch: LEAP Group Decodes Customer Signals

Understanding Customer Signals Like Never Before Well, here's one for the ol' playbook. The LEAP Group just dusted off their tool, HumanView, like an old car getting a fresh coat of paint and an engine overhaul. It's been rebuilt from the ground up, promising to turn those random blips of online chatter into actionable business insights. Not the same old dashboard mumbo...

Denarius Metals Unveils Technical Insight for Toral Project

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Amy Johnson Steps Up as GDIT President Amid Shifts

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...